These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12116820)
1. Coated stents: a novel approach to prevent in-stent restenosis. Curcio A; Torella D; Coppola C; Mongiardo A; Cireddu M; Falco M; Chiariello M; Indolfi C Ital Heart J; 2002 Jun; 3 Suppl 4():16S-19S. PubMed ID: 12116820 [No Abstract] [Full Text] [Related]
2. Modern strategies to prevent coronary restenosis. Chieffo A; Stankovic G; Colombo A Ital Heart J; 2002 Jun; 3 Suppl 4():9S-15S. PubMed ID: 12116826 [No Abstract] [Full Text] [Related]
3. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment. Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333 [TBL] [Abstract][Full Text] [Related]
4. The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured? Beyar R; Roguin A Eur Heart J; 2001 Nov; 22(22):2054-7. PubMed ID: 11686663 [No Abstract] [Full Text] [Related]
5. Drug coating improves stent performance. Health News; 2002 May; 8(5):5-6. PubMed ID: 12132409 [No Abstract] [Full Text] [Related]
6. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297 [TBL] [Abstract][Full Text] [Related]
7. [Drug-eluting coronary stents]. Fontos G Orv Hetil; 2006 Oct; 147(43):2059-66. PubMed ID: 17297752 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease. Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623 [TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review. Yan BP; Ajani AE; Waksman R Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355 [TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stent: the emerging technique for the prevention of restenosis. Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results. Mixon T; Fitzsimmons P J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892 [No Abstract] [Full Text] [Related]
13. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial versus registry data--comparing apples and ORCHIDs. Moliterno DJ Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505 [No Abstract] [Full Text] [Related]